Physician

Michael William Smith, M.D.

According to 2025 Medicare claims, Michael Smith, M.D. (NPI: 1205871035) practices rheumatology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Jackson, MO. This provider's primary affiliated billing organization is KANSAS CITY PHYSICIAN PARTNERS INC (NPI: 1831531466; TIN: 463233706) and primary practice location at 64086-5799. Smith is affiliated with the Centrus Health of Kansas LLC (ACO ID: A5305), participating under the MSSP model.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 685 traditional Medicare patients, billed 187,588 HCPCS/CPT codes, and received $3,326,737 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,541 prescription claims across 609 beneficiaries totaling $1,095,349 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 1 records totaling $750. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $954,156 to $3,326,737. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $242,124 to $1,095,349. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	613	81,929	$954,156
2016	627	85,304	$1,268,803
2017	788	119,277	$1,738,038
2018	752	106,148	$1,885,002
2019	833	136,294	$2,483,408
2020	737	123,921	$2,370,864
2021	729	126,043	$2,234,884
2022	708	135,328	$2,186,053
2023	653	142,779	$2,569,242
2024	685	187,588	$3,326,737

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	427	2,459	$242,124
2016	478	3,100	$488,392
2017	518	3,387	$614,188
2018	499	3,140	$662,043
2019	557	3,247	$742,982
2020	570	3,348	$1,086,477
2021	570	3,364	$1,072,062
2022	559	3,318	$1,263,184
2023	563	3,484	$1,303,227
2024	609	3,541	$1,095,349

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	395	791	$84
36415	Insertion of needle into vein for collection of blood sample	389	1,005	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	269	801	$7
86140	Measurement c-reactive protein for detection of infection or inflammation	342	858	$5
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	294	653	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	34	1,216	$309,341
Xeljanz Xr	Tofacitinib Citrate	18	840	$157,732
Otezla	Apremilast	24	720	$116,913
Rinvoq	Upadacitinib	13	390	$83,790
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	1,099	72,455	$48,765

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$750	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael William Smith, M.D.?

Tedicare shows public-source Medicare data for Michael William Smith, M.D. (NPI 1205871035), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael William Smith, M.D. have ACO affiliation data?

Michael William Smith, M.D. is shown with ACO affiliation data for Centrus Health of Kansas LLC (MSSP, ACO ID A5305).

What billing organization is linked to Michael William Smith, M.D.?

Michael William Smith, M.D. is linked to KANSAS CITY PHYSICIAN PARTNERS INC (billing NPI 1831531466) in the available physician profile data.

Does Michael William Smith, M.D. have Open Payments data?

Michael William Smith, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.